Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02234947 · ClinicalTrials.gov registry record
Pancreas Volume in Preclinical Type 1 Diabetes
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 246
- Enrollment target
NCT02234947 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 246 participants.
The verdict
NCT02234947 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 246 participants
- Enrollment target
Study Summary
Type 1 diabetes (T1D) is characterized by a progressive destruction of insulin producing beta cells, resulting in a lifelong dependence on exogenous insulin. While beta cells make up less than 1% of the pancreas, studies have demonstrated that T1D is associated with a marked reduction of pancreatic mass at diagnosis and as the disease progresses. As such, if pancreatic volume assessment, by ultrasonography (US) or MRI (Magnetic Resonance Imaging), could be utilized as a marker of beta cell function in high risk patients, non-invasive pancreatic imaging could become an important part of staging diabetes risk. As such, the primary goal of this study is to measure pancreatic volume and compare differences in volume between new onset T1D patients, antibody positive subjects at risk for diabetes, antibody negative individuals, and healthy controls.
Interventions
- PROCEDURE MRI, US, and blood samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2013-11 |
| Est. Completion | 2023-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02234947
The ClinicalTrials.gov registry entry for NCT02234947 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI, US, and blood samples is the first listed.
NCT02234947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02234947 about?
NCT02234947 is a clinical study titled "Pancreas Volume in Preclinical Type 1 Diabetes". Type 1 diabetes (T1D) is characterized by a progressive destruction of insulin producing beta cells, resulting in a lifelong dependence on exogenous insulin. While beta cells make up less than 1% of the pancreas, studies have demonstrated that T1D is associated with a marked reduction of pancreatic ...
What is the current status of trial NCT02234947?
This trial is currently completed. The enrollment target is 246 participants. The study started on 2013-11. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT02234947?
The interventions under investigation include: MRI, US, and blood samples (PROCEDURE).
Who is sponsoring clinical trial NCT02234947?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.